A detailed history of Burkett Financial Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Burkett Financial Services, LLC holds 412 shares of BMY stock, worth $22,977. This represents 0.01% of its overall portfolio holdings.

Number of Shares
412
Previous 601 31.45%
Holding current value
$22,977
Previous $25 Million 14.66%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$39.66 - $51.75 $7,495 - $9,780
-189 Reduced 31.45%
412 $21.3 Million
Q2 2024

Jul 10, 2024

SELL
$40.25 - $52.99 $43,268 - $56,964
-1,075 Reduced 64.14%
601 $25 Million
Q1 2024

Apr 01, 2024

BUY
$47.98 - $54.4 $959 - $1,088
20 Added 1.21%
1,676 $90.9 Million
Q4 2023

Feb 12, 2024

BUY
$48.48 - $57.85 $80,282 - $95,799
1,656 New
1,656 $85 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Burkett Financial Services, LLC Portfolio

Follow Burkett Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burkett Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burkett Financial Services, LLC with notifications on news.